The study of genetic variations (mutations) is currently undergoing a revolution in the field of targeted therapeutics; especially for the treatment of cancer. DiaCarta has innovative technologies that allow the rapid detection of known genetic variations that affect a patients response to drugs. DiaCarta's Molecular test kits are aimed at supporting the continuing growth in personalized therapies for cancer.
DiaCarta has a suite of Somatic Mutation tests including KRAS, NRAS, BRAF, EGFR, ALK, JAK2, PIK3CA, c-KIT and PDGFR that cover all of the important genetic variations important in targeted therapy.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
